SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-09-001492
Filing Date
2009-10-22
Accepted
2009-10-22 16:16:30
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 poniard_sch13g.htm SC 13G 176153
  Complete submission text file 0000929638-09-001492.txt   178305
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-40119 | Film No.: 091132652
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G